Diovan HCT (valsartan)
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
second-line treatment of hypertension
General Information
Diovan HCT has been approved for second-line treatment of
hypertension. Diovan HCT is a combination of an angiotensin II
receptor blocker (ARB)--a first line treatment that lowers blood
pressure with an overall incidence of side effects comparable to
placebo--and a diuretic, which is commonly used with other
therapies to provide additional blood pressure lowering.